San Diego-based healthcare company Truvian Sciences wants to disrupt the $80 billion blood-testing market. The company closed a $27.1 million series B financing round, led by GreatPoint Ventures
San Diego-based healthcare company Truvian Sciences wants to disrupt the $80 billion blood-testing market. The company closed a $27.1 million series B financing round, led by GreatPoint Ventures